Pembrolizumab in Treating Participants With Leukoplakia

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Pembrolizumab in Treating Participants With Leukoplakia	Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, leukoplakia, neoplasm, precancerous condition	Recruiting	Phase 2	2026-08-20		NCT03603223

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Jonsson Comprehensive Cancer Center	115
Merck Sharp & Dohme LLC	650

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
UC San Diego Moores Cancer Center	La Jolla	United States	199
UCLA / Jonsson Comprehensive Cancer Center	Los Angeles	United States	126
USC / Norris Comprehensive Cancer Center	Los Angeles	United States	249

Clinical trials